TSHR; | |
TDP1; BLM; RECQL; ALOX15; HSD17B10; | |
PIM1; CSNK2A1; MAPK1; | |
ESR1; ESR2; | |
ELANE; | |
HIF1A; | |
MAPT; LMNA; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Serine protease | ELANE | Leukocyte elastase | P08246 | CHEMBL248 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 9.167E-07 | 1.996E-02 | ESR1, ESR2 |
MF | GO:0005488; binding | GO:0051879; Hsp90 protein binding | 3.930E-06 | 2.392E-02 | CSNK2A1, HIF1A, MAPT |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 5.494E-06 | 2.392E-02 | ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 5.494E-06 | 2.392E-02 | CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0009378; four-way junction helicase activity | 9.151E-06 | 2.846E-02 | BLM, RECQL |
BP | GO:0008283; cell proliferation | GO:0008284; positive regulation of cell proliferation | 1.304E-05 | 3.034E-02 | CSNK2A1, ELANE, ESR1, HIF1A, MAPK1, PIM1, TSHR |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.372E-05 | 3.034E-02 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0034641; cellular nitrogen compound metabolic process | 1.533E-05 | 3.034E-02 | BLM, CSNK2A1, CYP2C9, CYP3A4, ELANE, ESR1, ESR2, HIF1A, HSD17B10, MAPK1, RECQL, SMN1, SMN2, TDP1 |
CC | GO:0044464; cell part | GO:0005737; cytoplasm | 1.503E-05 | 3.034E-02 | BLM, CYP3A4, ELANE, ESR1, HIF1A, HSD17B10, MAPK1, MAPT, PIM1, RECQL, SMN1, SMN2, TDP1 |
BP | GO:0009987; cellular process | GO:0019896; axonal transport of mitochondrion | 3.286E-05 | 3.253E-02 | HIF1A, MAPT |
BP | GO:0009987; cellular process | GO:0000733; DNA strand renaturation | 3.286E-05 | 3.253E-02 | BLM, RECQL |
CC | GO:0043226; organelle | GO:0043229; intracellular organelle | 2.439E-05 | 3.253E-02 | ALOX15, BLM, CSNK2A1, CYP2C9, CYP3A4, ELANE, ESR1, ESR2, HIF1A, HSD17B10, LMNA, MAPK1, MAPT, PIM1, RECQL, SMN1, SMN2, TDP1 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 3.714E-05 | 3.517E-02 | HIF1A, MAPK1, MAPT |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 6.015E-05 | 4.225E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.615E-06 | 3.085E-04 | CYP2C9, ALOX15, CYP3A4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 4.159E-05 | 2.454E-03 | MAPK1, ESR1, ESR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 1.076E-04 | 4.233E-03 | MAPK1, ESR1, ESR2 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.552E-04 | 4.273E-03 | CYP2C9, ALOX15, MAPK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.811E-04 | 4.273E-03 | MAPK1, ESR1, HIF1A |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 8.855E-04 | 1.493E-02 | MAPK1, HIF1A, ESR1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 5.110E-04 | 1.005E-02 | MAPK1, MAPT, HSD17B10 |
09160 Human Diseases | 09161 Cancers | hsa05211 | Renal cell carcinoma | 1.769E-03 | 1.628E-02 | MAPK1, HIF1A |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.716E-03 | 1.628E-02 | CYP2C9, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.822E-03 | 1.628E-02 | MAPK1, HIF1A |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|